# OnCo record kim-chi (person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/people/kim-chi/>
  a schema:Person ;
  onco:kind "person" ;
  schema:identifier "kim-chi" ;
  schema:name "Kim N. Chi"@en ;
  schema:description "Led TITAN and MAGNITUDE, bringing apalutamide to hormone-sensitive disease and niraparib to HRR-mutant prostate cancer."@en ;
  schema:url <https://onco.cc/people/kim-chi/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/?term=Chi%20KN%5BAuthor%5D%20prostate%20apalutamide%20OR%20niraparib> ;
  onco:tag "prostate", "trialist", "canada" ;
  schema:jobTitle "Medical Oncologist and Chief Medical Officer, BC Cancer; Professor, University of British Columbia" ;
  onco:cancers <https://onco.cc/cancers/prostate/> ;
  onco:technologies <https://onco.cc/technologies/parp-inhibitor/>, <https://onco.cc/technologies/liquid-biopsy/> ;
  onco:targets <https://onco.cc/targets/androgen-receptor/>, <https://onco.cc/targets/parp/>, <https://onco.cc/targets/brca/> ;
  onco:drugs <https://onco.cc/drugs/niraparib/>, <https://onco.cc/drugs/abiraterone/> ;
  onco:institutions <https://onco.cc/institutions/bc-cancer/> ;
  onco:trials <https://onco.cc/trials/magnitude/> ;
  schema:affiliation <https://onco.cc/institutions/bc-cancer/> .